Q-and-A List by EMA on the Centralised Procedure Extended

The European Medicines Agency EMA maintains a questions-and-answers list in which questions are clarified that are important in the context of the submission of an application for a marketing authorisation under the Centralised System. These FAQs are complemented or revised at irregular intervals or when the occasion arises. Not long ago 5 new questions were added to this list:

  • Can my medicinal product be submitted under the Centralised Procedure?
  • How and when is an enquiry for eligibility for the Centralised Procedure to be submitted?
  • According to which procedure are appointments to be made with the CHMP Rapporteur/Co-Rapporteur and their assessment teams?
  • Is my medicinal product entitled to an accelerated assessment?
  • When is the application for the marketing authorisation to be submitted?

This list consists of a total of 53 questions/answers and covers the essential topics in connection with the submission of an application for a marketing authorisation under the Centralised System. On the EMA website, this Q&A document can be found under the sections "Human Medicines" - "Application Procedures" - "Pre-submission Guidance" - "Questions & Answers". This link leads you directly to the document.

For enquiries during the preparation phase for the application for a marketing authorisation under the Centralised Procedure, the EMA has also published additional explanations, a mandatory pre-submission request form and an application form for a pre-submission meeting. The forms are also available in the section "Pre-submission Guidance" with corresponding links. The "Explanatory Note on the Pre-submission Request Form" can be found here.

Author:
Dr Gerhard Becker
On behalf of the European Compliance Academy (ECA)

Cookies help us in providing our services. By using our services, you agree that we use cookies. Further information

OK

Conference Recommendations

Go back

GMP Conferences by Topics

Cookies help us in providing our services. By using our services, you agree that we use cookies. Further information

OK